Advertisement
Screener

DNA X, Inc. (SONM) Spending and interest coverage

DNA X, Inc. (SONM) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months(m)Share-based compensation / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)Research and Development Expense
Revenue(m)Revenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation727.00K USDShare-based Payment Arrangement, Noncash Expense
Operating income-7.96M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30(m)(m)$727.00K$-7.96M(m)(m)(m)(m)(m)
2026-03-31(m)(m)$1.55M$-8.15M$1.00M(m)(m)-8.11×Reported
2025-12-31(m)(m)$1.54M$-5.41M$945.00K(m)(m)-5.72×Reported
2025-09-30$15.23M$59.39M$1.74M$-32.17M(m)25.64%2.93%(m)(m)
2025-06-30$15.76M$58.20M$1.95M$-30.57M(m)27.09%3.34%(m)(m)
2025-03-31$15.41M$58.52M$1.49M$-30.30M(m)26.34%2.55%(m)(m)
2024-12-31$14.23M$50.92M$1.52M$-33.64M(m)27.96%2.99%(m)(m)
2024-09-30$2.65M$49.09M$1.63M$-12.79M(m)5.41%3.31%(m)(m)
2024-06-30$2.68M$69.29M$1.63M$-9.73M(m)3.87%2.35%(m)(m)
2024-03-31$2.12M$84.61M$1.51M$-2.51M(m)2.51%1.79%(m)(m)
2023-12-31$1.77M$93.63M$1.50M$513.00K(m)1.89%1.60%(m)(m)
2023-09-30$2.06M$104.32M$1.45M$709.00K$30.00K1.98%1.39%23.63×Reported
2023-06-30$1.19M$97.25M$1.72M$-1.91M$28.00K1.22%1.77%-68.14×Reported
2023-03-31$3.91M$82.37M$1.58M$-6.88M$58.00K4.75%1.91%-118.53×Reported
2022-12-31$7.97M$69.83M$1.55M$-14.29M$97.00K11.42%2.22%-147.32×Reported
2022-09-30$10.62M$61.64M$1.46M$-24.97M(m)17.24%2.37%(m)(m)
2022-06-30$16.25M$55.59M$1.36M$-33.77M(m)29.23%2.45%(m)(m)
2022-03-31$17.20M$55.59M$1.07M$-36.03M(m)30.94%1.93%(m)(m)
2021-12-31$17.70M$54.57M$1.08M$-38.00M(m)32.43%1.99%(m)(m)
2021-09-30$19.46M$54.47M$1.08M$-33.72M(m)35.73%1.98%(m)(m)
2021-06-30$17.36M$54.42M$1.10M$-29.11M(m)31.90%2.03%(m)(m)
2021-03-31$16.95M$63.53M$1.16M$-29.25M(m)26.68%1.83%(m)(m)
2020-12-31$16.22M$63.99M$1.09M$-29.26M(m)25.34%1.70%(m)(m)
2020-09-30$15.65M$65.33M$1.17M$-29.20M(m)23.95%1.79%(m)(m)
2020-06-30$18.91M$79.78M$1.16M$-29.34M(m)23.70%1.46%(m)(m)
2020-03-31$23.04M$102.47M$6.48M$-27.30M(m)22.48%6.33%(m)(m)
2019-12-31$26.06M$116.25M$6.31M$-22.38M(m)22.42%5.43%(m)(m)
2019-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-12-31$23.25M$135.66M$252.00K$5.39M(m)17.14%0.19%(m)(m)
2018-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
CLEARONE INC (CLRO)United States$0.009B
FRANKLIN WIRELESS CORP (FKWL)United States$0.028B-61.80
FiEE, Inc. (FIEE)Japan$0.033B8.06
Clearfield, Inc. (CLFD)United States$0.415B-74.88
ADTRAN Holdings, Inc. (ADTN)United States$0.565B-43.25
Fabrinet (FN)$14.287B39.79
CIENA CORP (CIEN)United States$50.874B81.72